For Preventing Events after TAVI in Patients with Atrial Fibrillation, NOAC Is a Viable Option

New Data Stress Large Anticoagulant Benefit in Elderly and Frail Patients with Atrial Fibrillation

ARIADNE Real-World Study: Confirming Outcomes and Wellbeing of Patients with Chronic Heart Failure

THEMIS-PCI: Potent Dual Antiplatelet Regimen Found Beneficial in Diabetic Patients with CAD and History of PCI

For Stroke Prevention in Patients with Atrial Fibrillation Undergoing PCI, Double Antiplatelet Therapy Found to be Safe

Landmark DAPA-HF Trial: New Approach to Treatment of Heart Failure

Clarifying the Heart Failure Story: Data from PARAGON-HF, EVALUATE-HF, and PROVE-HF

Once Stable, Many Decompensated Heart Failure Patients Can Be Initiated on Life-Saving Medication

Progress in Isolating the Mechanisms of New Standards in Heart Failure Therapy

CANTOS Trial Advances Inflammatory Hypothesis of Coronary Artery Disease

PCSK9 Inhibitors Required to Reach LDL-C Goals in Many High-risk Patients

PCSK9 Inhibitor Achieves Persistent LDL-C Control and Sustained Safety in a Challenging Population